SABBY MANAGEMENT, LLC Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for SABBY MANAGEMENT, LLC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of SABBY MANAGEMENT, LLC. SABBY MANAGEMENT, LLC is 10% Owner in ReShape Lifesciences Inc. ($ETRM) and 10% Owner in Rosetta Genomics Ltd. ($ROSG) and 10% Owner in Akari Therapeutics Plc ($AKTX).
Latest Insider Trading Transactions of SABBY MANAGEMENT, LLC
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, AKTX, RSLS, ROSG
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 04 2019 | ETRM | ReShape Lifescienc ... | SABBY MANAGEMENT, LLC | 10% Owner | Option Exercise | J | 0.00 | 1,192,000 | 0 | 1,192,000 | |
| Feb 04 2019 | ETRM | ReShape Lifescienc ... | SABBY MANAGEMENT, LLC | 10% Owner | Sell | P | 0.00 | 1,192,000 | 0 | 507 | 1.2 M to 507 (-99.96 %) |
| Feb 04 2019 | ETRM | ReShape Lifescienc ... | SABBY MANAGEMENT, LLC | 10% Owner | Buy | P | 0.27 | 10,301 | 2,815 | 1,192,507 | 1.2 M to 1.2 M (+0.87 %) |
| Jan 31 2019 | ETRM | ReShape Lifescienc ... | SABBY MANAGEMENT, LLC | 10% Owner | Buy | P | 0.28 | 48,000 | 13,440 | 1,182,206 | 1.1 M to 1.2 M (+4.23 %) |
| Jan 31 2019 | ETRM | ReShape Lifescienc ... | SABBY MANAGEMENT, LLC | 10% Owner | Buy | P | 0.28 | 12,200 | 3,390 | 1,134,206 | 1.1 M to 1.1 M (+1.09 %) |
| Jan 28 2019 | ETRM | ReShape Lifescienc ... | SABBY MANAGEMENT, LLC | 10% Owner | Buy | P | 0.27 | 15,595 | 4,237 | 1,122,006 | 1.1 M to 1.1 M (+1.41 %) |
| Jan 28 2019 | ETRM | ReShape Lifescienc ... | SABBY MANAGEMENT, LLC | 10% Owner | Buy | P | 0.26 | 6,190 | 1,578 | 1,106,411 | 1.1 M to 1.1 M (+0.56 %) |
| Jan 24 2019 | ETRM | ReShape Lifescienc ... | SABBY MANAGEMENT, LLC | 10% Owner | Buy | P | 0.28 | 5,766 | 1,609 | 1,100,221 | 1.1 M to 1.1 M (+0.53 %) |
| Jan 22 2019 | ETRM | ReShape Lifescienc ... | SABBY MANAGEMENT, LLC | 10% Owner | Buy | P | 0.28 | 24,334 | 6,787 | 1,094,455 | 1.1 M to 1.1 M (+2.27 %) |
| Jan 22 2019 | ETRM | ReShape Lifescienc ... | SABBY MANAGEMENT, LLC | 10% Owner | Buy | P | 0.28 | 24,334 | 6,787 | 1,094,455 | 1.1 M to 1.1 M (+2.27 %) |
| Jan 22 2019 | ETRM | ReShape Lifescienc ... | SABBY MANAGEMENT, LLC | 10% Owner | Buy | P | 0.28 | 52 | 15 | 1,070,121 | 1.1 M to 1.1 M (0.00 %) |
| Jan 22 2019 | ETRM | ReShape Lifescienc ... | SABBY MANAGEMENT, LLC | 10% Owner | Buy | P | 0.28 | 52 | 15 | 1,070,121 | 1.1 M to 1.1 M (0.00 %) |
| Jan 17 2019 | ETRM | ReShape Lifescienc ... | SABBY MANAGEMENT, LLC | 10% Owner | Buy | P | 0.26 | 4,700 | 1,236 | 1,070,069 | 1.1 M to 1.1 M (+0.44 %) |
| Jan 17 2019 | ETRM | ReShape Lifescienc ... | SABBY MANAGEMENT, LLC | 10% Owner | Buy | P | 0.27 | 21,961 | 5,936 | 1,065,369 | 1 M to 1.1 M (+2.10 %) |
| Jan 17 2019 | ETRM | ReShape Lifescienc ... | SABBY MANAGEMENT, LLC | 10% Owner | Buy | P | 0.24 | 167,760 | 39,440 | 1,043,408 | 875.6 K to 1 M (+19.16 %) |
| Mar 19 2018 | ROSG | Rosetta Genomics L ... | SABBY MANAGEMENT, LLC | 10% Owner | Buy | P | 0.42 | 9 | 4 | 934,608 | 934.6 K to 934.6 K (0.00 %) |
| Mar 19 2018 | ROSG | Rosetta Genomics L ... | SABBY MANAGEMENT, LLC | 10% Owner | Buy | P | 0.44 | 33,413 | 14,545 | 934,599 | 901.2 K to 934.6 K (+3.71 %) |
| Mar 19 2018 | ROSG | Rosetta Genomics L ... | SABBY MANAGEMENT, LLC | 10% Owner | Buy | P | 0.43 | 9,247 | 3,971 | 901,186 | 891.9 K to 901.2 K (+1.04 %) |
| Mar 19 2018 | ROSG | Rosetta Genomics L ... | SABBY MANAGEMENT, LLC | 10% Owner | Buy | P | 0.43 | 20,229 | 8,620 | 891,939 | 871.7 K to 891.9 K (+2.32 %) |
| Mar 19 2018 | ROSG | Rosetta Genomics L ... | SABBY MANAGEMENT, LLC | 10% Owner | Buy | P | 0.42 | 1,400 | 590 | 871,710 | 870.3 K to 871.7 K (+0.16 %) |
| Mar 16 2018 | ROSG | Rosetta Genomics L ... | SABBY MANAGEMENT, LLC | 10% Owner | Buy | P | 0.42 | 14,400 | 6,055 | 870,310 | 855.9 K to 870.3 K (+1.68 %) |
| Mar 16 2018 | ROSG | Rosetta Genomics L ... | SABBY MANAGEMENT, LLC | 10% Owner | Buy | P | 0.42 | 13,545 | 5,689 | 855,910 | 842.4 K to 855.9 K (+1.61 %) |
| Mar 16 2018 | ROSG | Rosetta Genomics L ... | SABBY MANAGEMENT, LLC | 10% Owner | Buy | P | 0.42 | 3,566 | 1,498 | 842,365 | 838.8 K to 842.4 K (+0.43 %) |
| Mar 16 2018 | ROSG | Rosetta Genomics L ... | SABBY MANAGEMENT, LLC | 10% Owner | Buy | P | 0.42 | 34 | 14 | 838,799 | 838.8 K to 838.8 K (0.00 %) |
| Mar 16 2018 | ROSG | Rosetta Genomics L ... | SABBY MANAGEMENT, LLC | 10% Owner | Buy | P | 0.42 | 15,025 | 6,318 | 838,765 | 823.7 K to 838.8 K (+1.82 %) |
| Mar 16 2018 | ROSG | Rosetta Genomics L ... | SABBY MANAGEMENT, LLC | 10% Owner | Buy | P | 0.42 | 50,020 | 21,013 | 823,740 | 773.7 K to 823.7 K (+6.46 %) |
| Mar 16 2018 | ROSG | Rosetta Genomics L ... | SABBY MANAGEMENT, LLC | 10% Owner | Buy | P | 0.42 | 17,900 | 7,590 | 773,720 | 755.8 K to 773.7 K (+2.37 %) |
| Mar 16 2018 | ROSG | Rosetta Genomics L ... | SABBY MANAGEMENT, LLC | 10% Owner | Buy | P | 0.42 | 200 | 84 | 755,820 | 755.6 K to 755.8 K (+0.03 %) |
| Mar 16 2018 | ROSG | Rosetta Genomics L ... | SABBY MANAGEMENT, LLC | 10% Owner | Buy | P | 0.42 | 4,271 | 1,794 | 755,620 | 751.3 K to 755.6 K (+0.57 %) |
| Mar 16 2018 | ROSG | Rosetta Genomics L ... | SABBY MANAGEMENT, LLC | 10% Owner | Buy | P | 0.42 | 800 | 336 | 751,349 | 750.5 K to 751.3 K (+0.11 %) |
| Mar 14 2018 | ROSG | Rosetta Genomics L ... | SABBY MANAGEMENT, LLC | 10% Owner | Buy | P | 0.42 | 6,329 | 2,658 | 750,549 | 744.2 K to 750.5 K (+0.85 %) |
| Mar 14 2018 | ROSG | Rosetta Genomics L ... | SABBY MANAGEMENT, LLC | 10% Owner | Buy | P | 0.42 | 30,990 | 13,025 | 744,220 | 713.2 K to 744.2 K (+4.35 %) |
| Mar 14 2018 | ROSG | Rosetta Genomics L ... | SABBY MANAGEMENT, LLC | 10% Owner | Buy | P | 0.42 | 10,000 | 4,200 | 713,230 | 703.2 K to 713.2 K (+1.42 %) |
| Mar 14 2018 | ROSG | Rosetta Genomics L ... | SABBY MANAGEMENT, LLC | 10% Owner | Buy | P | 0.41 | 12,390 | 5,081 | 703,230 | 690.8 K to 703.2 K (+1.79 %) |
| Mar 14 2018 | ROSG | Rosetta Genomics L ... | SABBY MANAGEMENT, LLC | 10% Owner | Buy | P | 0.42 | 10,605 | 4,442 | 690,840 | 680.2 K to 690.8 K (+1.56 %) |
| Mar 14 2018 | ROSG | Rosetta Genomics L ... | SABBY MANAGEMENT, LLC | 10% Owner | Buy | P | 0.42 | 24,162 | 10,114 | 680,235 | 656.1 K to 680.2 K (+3.68 %) |
| Mar 14 2018 | ROSG | Rosetta Genomics L ... | SABBY MANAGEMENT, LLC | 10% Owner | Buy | P | 0.42 | 24,600 | 10,295 | 656,073 | 631.5 K to 656.1 K (+3.90 %) |
| Mar 14 2018 | ROSG | Rosetta Genomics L ... | SABBY MANAGEMENT, LLC | 10% Owner | Buy | P | 0.41 | 21,800 | 8,975 | 631,473 | 609.7 K to 631.5 K (+3.58 %) |
| Mar 14 2018 | ROSG | Rosetta Genomics L ... | SABBY MANAGEMENT, LLC | 10% Owner | Buy | P | 0.41 | 11,521 | 4,724 | 609,673 | 598.2 K to 609.7 K (+1.93 %) |
| Mar 14 2018 | ROSG | Rosetta Genomics L ... | SABBY MANAGEMENT, LLC | 10% Owner | Buy | P | 0.42 | 2,604 | 1,093 | 598,152 | 595.5 K to 598.2 K (+0.44 %) |
| Mar 14 2018 | ROSG | Rosetta Genomics L ... | SABBY MANAGEMENT, LLC | 10% Owner | Buy | P | 0.40 | 454 | 182 | 595,548 | 595.1 K to 595.5 K (+0.08 %) |
| Mar 14 2018 | ROSG | Rosetta Genomics L ... | SABBY MANAGEMENT, LLC | 10% Owner | Buy | P | 0.42 | 20,373 | 8,555 | 595,094 | 574.7 K to 595.1 K (+3.54 %) |
| Apr 17 2014 | AKTX | Akari Therapeutics ... | SABBY MANAGEMENT, LLC | 10% Owner | Buy | P | 5.00 | 17,100 | 85,500 | 778,030 | 760.9 K to 778 K (+2.25 %) |
| Apr 17 2014 | AKTX | Akari Therapeutics ... | SABBY MANAGEMENT, LLC | 10% Owner | Buy | P | 5.21 | 3,000 | 15,630 | 760,930 | 757.9 K to 760.9 K (+0.40 %) |
| Apr 11 2014 | AKTX | Akari Therapeutics ... | SABBY MANAGEMENT, LLC | 10% Owner | Buy | P | 5.15 | 100 | 515 | 757,930 | 757.8 K to 757.9 K (+0.01 %) |
| Apr 11 2014 | AKTX | Akari Therapeutics ... | SABBY MANAGEMENT, LLC | 10% Owner | Buy | P | 5.25 | 1,400 | 7,350 | 757,830 | 756.4 K to 757.8 K (+0.19 %) |
| Apr 11 2014 | AKTX | Akari Therapeutics ... | SABBY MANAGEMENT, LLC | 10% Owner | Buy | P | 5.51 | 1,075 | 5,923 | 756,430 | 755.4 K to 756.4 K (+0.14 %) |
| Apr 08 2014 | AKTX | Akari Therapeutics ... | SABBY MANAGEMENT, LLC | 10% Owner | Buy | P | 5.36 | 35,500 | 190,280 | 755,355 | 719.9 K to 755.4 K (+4.93 %) |
| Apr 08 2014 | AKTX | Akari Therapeutics ... | SABBY MANAGEMENT, LLC | 10% Owner | Buy | P | 6.00 | 3,754 | 22,524 | 719,855 | 716.1 K to 719.9 K (+0.52 %) |
| Apr 08 2014 | AKTX | Akari Therapeutics ... | SABBY MANAGEMENT, LLC | 10% Owner | Buy | P | 5.64 | 16,900 | 95,316 | 716,101 | 699.2 K to 716.1 K (+2.42 %) |
| Apr 08 2014 | AKTX | Akari Therapeutics ... | SABBY MANAGEMENT, LLC | 10% Owner | Buy | P | 6.08 | 11,250 | 68,400 | 699,201 | 688 K to 699.2 K (+1.64 %) |
| Apr 08 2014 | AKTX | Akari Therapeutics ... | SABBY MANAGEMENT, LLC | 10% Owner | Buy | P | 6.00 | 1,000 | 6,000 | 687,951 | 687 K to 688 K (+0.15 %) |
| Apr 02 2014 | AKTX | Akari Therapeutics ... | SABBY MANAGEMENT, LLC | 10% Owner | Buy | P | 6.15 | 2,500 | 15,375 | 686,951 | 684.5 K to 687 K (+0.37 %) |
| Apr 02 2014 | AKTX | Akari Therapeutics ... | SABBY MANAGEMENT, LLC | 10% Owner | Buy | P | 6.12 | 7,496 | 45,876 | 684,451 | 677 K to 684.5 K (+1.11 %) |
| Apr 02 2014 | AKTX | Akari Therapeutics ... | SABBY MANAGEMENT, LLC | 10% Owner | Buy | P | 6.08 | 7,375 | 44,840 | 676,955 | 669.6 K to 677 K (+1.10 %) |
| Apr 02 2014 | AKTX | Akari Therapeutics ... | SABBY MANAGEMENT, LLC | 10% Owner | Buy | P | 6.18 | 500 | 3,090 | 669,580 | 669.1 K to 669.6 K (+0.07 %) |
| Apr 02 2014 | AKTX | Akari Therapeutics ... | SABBY MANAGEMENT, LLC | 10% Owner | Buy | P | 6.65 | 2,400 | 15,960 | 661,144 | 658.7 K to 661.1 K (+0.36 %) |
| Apr 02 2014 | AKTX | Akari Therapeutics ... | SABBY MANAGEMENT, LLC | 10% Owner | Buy | P | 6.35 | 7,936 | 50,394 | 669,080 | 661.1 K to 669.1 K (+1.20 %) |
| Mar 27 2014 | AKTX | Akari Therapeutics ... | SABBY MANAGEMENT, LLC | 10% Owner | Buy | P | 6.61 | 1,700 | 11,237 | 658,744 | 657 K to 658.7 K (+0.26 %) |
| Mar 27 2014 | AKTX | Akari Therapeutics ... | SABBY MANAGEMENT, LLC | 10% Owner | Buy | P | 6.65 | 13,300 | 88,445 | 657,044 | 643.7 K to 657 K (+2.07 %) |
| Mar 27 2014 | AKTX | Akari Therapeutics ... | SABBY MANAGEMENT, LLC | 10% Owner | Buy | P | 6.86 | 900 | 6,174 | 643,744 | 642.8 K to 643.7 K (+0.14 %) |
| Mar 27 2014 | AKTX | Akari Therapeutics ... | SABBY MANAGEMENT, LLC | 10% Owner | Buy | P | 6.90 | 303 | 2,091 | 642,844 | 642.5 K to 642.8 K (+0.05 %) |
| Mar 24 2014 | AKTX | Akari Therapeutics ... | SABBY MANAGEMENT, LLC | 10% Owner | Buy | P | 6.71 | 2,400 | 16,104 | 642,541 | 640.1 K to 642.5 K (+0.37 %) |
| Mar 24 2014 | AKTX | Akari Therapeutics ... | SABBY MANAGEMENT, LLC | 10% Owner | Buy | P | 6.83 | 4,900 | 33,467 | 640,141 | 635.2 K to 640.1 K (+0.77 %) |
| Mar 24 2014 | AKTX | Akari Therapeutics ... | SABBY MANAGEMENT, LLC | 10% Owner | Buy | P | 6.90 | 3,800 | 26,220 | 635,241 | 631.4 K to 635.2 K (+0.60 %) |
Page: 1